Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Revenues
Costs and expenses:        
General and administrative costs, including $464,483 and $32,030 to related parties for the three months ended September 30, 2020 and 2019, respectively, and $518,483 and $395,631 to related parties for the nine months ended September 30, 2020 and 2019, respectively 802,273 522,360 1,350,201 1,460,551
Research and development costs, including $670,715 of stock-based compensation costs to consultant for the three months and nine months ended September 30, 2020 799,420 570,601 1,012,038 699,038
Total costs and expenses 1,601,693 1,092,961 2,362,239 2,159,589
Loss from operations (1,601,693) (1,092,961) (2,362,239) (2,159,589)
Interest income 38 13,889 4,284 41,317
Net loss $ (1,601,655) $ (1,079,072) $ (2,357,955) $ (2,118,272)
Net loss per common share - basic and diluted $ (0.02) $ (0.02) $ (0.04) $ (0.03)
Weighted average common shares outstanding - basic and diluted 67,045,814 67,045,814 67,045,814 67,045,814